Market Overview

Benzinga's Top Initiations

Related BCEI
MLV & Co Believes Catalyst Program Appears Promising For Bonanza Creek Energy
Benzinga's Top Upgrades

Analysts at Deutsche Bank initiated coverage on shares of Eloqua (NASDAQ: ELOQ) with a “buy” rating. Eloqua's shares closed at $14.44 on Friday. Eloqua's trailing-twelve-month revenue is $84.67 million.

RBC Capital initiated coverage on shares of Bonanza Creek Energy (NYSE: BCEI) with a “buy” rating. Bonanza Creek Energy's shares closed at $20.34 on Friday. Bonanza Creek Energy had $2.61 million in total cash for the latest quarter.

William Blair initiated coverage on shares of Globus Medical (NYSE: GMED) with an “outperform” rating. Globus Medical's stock closed at $14.68 on Friday. Globus Medical's trailing-twelve-month operating margin is 29.86%.

ThinkEquity initiated coverage on shares of Sarepta Therapeutics (NASDAQ: SRPT) with a “buy” rating. Sarepta Therapeutics' shares closed at $10.78 on Friday. Sarepta Therapeutics' 52-week trading range is $3.00-$10.98.

Latest Ratings for ELOQ

DateFirmActionFromTo
Jan 2013JMP SecuritiesDowngradesMarket OutperformMarket Perform
Dec 2012JP MorganDowngradesOverweightNeutral
Oct 2012JP MorganMaintainsOverweight

View More Analyst Ratings for ELOQ
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (ELOQ + BCEI)

Around the Web, We're Loving...

Get Benzinga's Newsletters